Bridging the Gap: Transforming Knowledge into Action
July 8-12, 2006, Washington, DC, USA
Tuesday, 11 July 2006 - 1:30 PM 174-1
Frontiers of Cancer Research
John Niederhuber, MD, National Cancer Institute, Building 31 - Room 11A48, 31 Center Drive, MSC 2590, Bethesda, MD 20892-2590
Current directions in cancer research hold promise for the future of diagnostics and therapeutics. The study of the cancer stem cell and how it relates to the tumor microenviroment and metastasis has provided us with an intriguing target for further investigation. Understanding these cells promises to provide us not only with a model of tumorigenesis, but a better understanding of therapeutic resistance, as well as a possible solution to such resistance. In addition, current efforts to identify therapeutic agents that specifically target stem cells promise to pay huge dividends in the future.